Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
Ten years experience of liposomal amphotericin B, AmBisome treatment in solid organ transplant recipients (SOT)
Our experience with AmBisome   <ul><li>More than 10 years experience in 383 patients.  </li></ul><ul><li>Two double blind ...
Fungal Infections - Morbidity /Mortality <ul><li>Invasive fungal infections contribute to the morbidity and mortality in S...
Incidence of invasive fungal infections at our center during the time periods 1989 to 1994 & 1996 <ul><li>Organ n V * FI I...
AmBisome prophylaxis   Liver transplant recipients Transplantation. 59: 1: 45-50, 1995. Transplant. Proc.27: 1195-1198, 19...
Study Design LTX  prophylaxis <ul><li>Double blind randomized, placebo controlled study </li></ul><ul><li>86 patients were...
Results Adverse Events LTX prophylaxis  all  84 patients
Results invasive fungal infections after prophylaxis in  LTX,  first year p<0.01 p<0.05
LTX prophylaxis;   Results early FI : Placebo group <ul><li>Invasive fungal infections </li></ul><ul><li>5 Candida albican...
LTX prophylaxis;   Results late FI : Placebo group <ul><li>Invasive fungal infections </li></ul><ul><li>4 Candida albicans...
LTX prophylaxis;   Results late FI : AmBisome group <ul><li>Invasive fungal infections </li></ul><ul><li>3 Aspergillus spp...
AmBisome treatment Solid organ transplant recipients, 10 year data
SOT  patients <ul><li>Patients treated between  Jan 1989 - March 1999 </li></ul><ul><li>196 solid organ transplant recipie...
SOT  patients <ul><li>123 liver (LTX) transplant recipients </li></ul><ul><li>3 liver and bone marrow transplant recipient...
AmBisome treatment data in SOT <ul><li>  Fungal Infection </li></ul><ul><li>AmBisome treatment Verified Suspected Prophyla...
Days with AmBisome
AmBisome dose   (mg/kg/d)
Total dose AmBisome  (gram)
Adverse events in SOT <ul><li>335 adverse events were reported </li></ul><ul><li>9  (3%) were regarded as caused by  AmBis...
Kidney function before, during and after AmBisome treatment measured as S-creatinine
Efficacy; Suspected FI in SOT <ul><li>75 patients recieved 79 episodes of treatment for suspected FI </li></ul><ul><li>57 ...
Proven invasive fungal infections in SOT <ul><li>A total of 56 proven infections were treated  in  50 patients </li></ul><...
Efficacy, proven invasive fungal infections in SOT <ul><li>Out of 50 patients with proven infections; </li></ul><ul><ul><l...
Conclusion solid organ transplantation <ul><li>10 years  experience of Ambisome treatment in solid organ transplant recipi...
General conclusion;  prophylaxis  & treatment in transplantation <ul><li>Prophylaxis with AmBisome </li></ul><ul><ul><li>E...
Upcoming SlideShare
Loading in …5
×

Ten years experience of liposomal amphotericin B, AmBisome ...

1,357 views

Published on

  • Have You Seen Linda Allen's new Candida System yet? It's called "Yeast Infection No More" I've read the whole thing (all 150 pages) and there's some great information in there about how to naturally and permanently eliminate your yeast infection without drugs, creams or any kind of gimmicks. I highly recommend it - it's very honest and straightforward without all the hype and b.s. you see all over the net these days. Here's the website where you can get more information: ➤➤ https://tinyurl.com/y3flbeje
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • I have suffered from a widening array of allergies and constant cravings for sugar and bread. I was miserable most of the time while taking allergy medication. After following your step-by-step directions for 6 weeks, I am recovering! I am now, as I write this lines, almost symptom free. I recommend anyone who is affected by allergy caused directly or indirectly by candida yeast infection to read your book. It is so easy to read (even for me - English is not my native language) and to apply. I cannot thank you enough for your counseling service and for the knowledge and health you have brought into my life. ■■■ http://ishbv.com/index7/pdf
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • I recommend everyone to take this book for what it is, and educate yourselves with this one tool in the fight against candida. It could improve your life tremendously. I am now doing SO much better and have already recommended this book to couple of my friends. ♣♣♣ https://tinyurl.com/y4uu6uch
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • Have You Seen Linda Allen's new Candida System yet? It's called "Yeast Infection No More" I've read the whole thing (all 150 pages) and there's some great information in there about how to naturally and permanently eliminate your yeast infection without drugs, creams or any kind of gimmicks. I highly recommend it - it's very honest and straightforward without all the hype and b.s. you see all over the net these days. Here's the website where you can get more information: ◆◆◆ https://tinyurl.com/y4uu6uch
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
  • The Yeast Infection No More book has literally saved my life. After years of getting no help from the established "medical profession" and getting sicker and afflicted by pain mood swings and depression, I bought your book and in less than5 weeks my chronic muscle aches and joint pain, caused by my candida yeast infection, have disappeared, and I literally tossed away my cane that I have been using for years. I couldn't believe it, it was nothing short of a miracle. I still can't believe it. Now, months later, the depression has also vanished. I no longer cry with no reason and I feel happier and energized. I am sure the protocols in your book have saved untold thousands of people like me from suffering and pain and "given us our lives back." I will never understand why don�t doctors tell us or investigate more on the subject of candidiasis. Two of my friends, one of them a naturopath had recommended that I try your program. And just like that, I was cured and liberated from years of misery. I have recommended your book to numerous people and all have received a great deal of relief. If only I had been told about it sooner, it would have saved me years of pain and exhaustion. I really tried everything. After 2 months on your program, people say that I look10 years younger, and they are right! Thank you very much for everything you have done for me! ■■■ https://tinyurl.com/y3flbeje
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here

Ten years experience of liposomal amphotericin B, AmBisome ...

  1. 1. Ten years experience of liposomal amphotericin B, AmBisome treatment in solid organ transplant recipients (SOT)
  2. 2. Our experience with AmBisome <ul><li>More than 10 years experience in 383 patients. </li></ul><ul><li>Two double blind placebo controlled randomized trials with AmBisome as prophylaxis </li></ul><ul><ul><li>Allogeneic & autologous BMT </li></ul></ul><ul><ul><li>Liver transplant recipients </li></ul></ul><ul><li>Three Retrospective analyses of treatment with respect to safety and efficacy </li></ul><ul><ul><li>Allogeneic BMT recipients (5 years) (79 patients) </li></ul></ul><ul><ul><li>Solid organ transplant recipients (10years) (196 patients) </li></ul></ul><ul><ul><li>Child recipients of transplant (7 years) (61 patients) </li></ul></ul>
  3. 3. Fungal Infections - Morbidity /Mortality <ul><li>Invasive fungal infections contribute to the morbidity and mortality in SOT recipients. </li></ul><ul><li>Reported incidence: up to 53 % </li></ul><ul><ul><ul><ul><li>Kidney 0 - 20 % </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Liver 4 - 42 % </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Pancreas 6 - 38 % </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Heart/lung 10 - 35 % </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Small bowel 33 - 53 % </li></ul></ul></ul></ul><ul><li>Reported mortality: up to 77 % for Candidosis up to 100 % for Aspergillosis </li></ul>
  4. 4. Incidence of invasive fungal infections at our center during the time periods 1989 to 1994 & 1996 <ul><li>Organ n V * FI Incid S ** FI Incid </li></ul><ul><li>Liver 240 21 9% 17 16 % </li></ul><ul><li>Kidney 540 5 1% 16 4 % </li></ul><ul><li>Kidney & </li></ul><ul><li>Pancreas 38 1 3% 9 26 % </li></ul><ul><li>BMT 199 17 9% 41 29 % </li></ul><ul><li>*VFI = verified fungal infection </li></ul><ul><li>**SFI = suspected fungal infection </li></ul>
  5. 5. AmBisome prophylaxis Liver transplant recipients Transplantation. 59: 1: 45-50, 1995. Transplant. Proc.27: 1195-1198, 1995.
  6. 6. Study Design LTX prophylaxis <ul><li>Double blind randomized, placebo controlled study </li></ul><ul><li>86 patients were randomized </li></ul><ul><li>Prophylactic treatment : </li></ul><ul><li>Treatment group : AmBisome, 1 mg/kg daily i.v. </li></ul><ul><li>Control group : Equal volume of placebo drug i.v. </li></ul><ul><li>Treatment during days 1 to 5 posttransplant </li></ul><ul><li>Evaluation criteria for efficacy: </li></ul><ul><li>77 patients who recieved all 5 days of prophylaxis </li></ul>
  7. 7. Results Adverse Events LTX prophylaxis all 84 patients
  8. 8. Results invasive fungal infections after prophylaxis in LTX, first year p<0.01 p<0.05
  9. 9. LTX prophylaxis; Results early FI : Placebo group <ul><li>Invasive fungal infections </li></ul><ul><li>5 Candida albicans inf: 4 peritonitis - abdomen cultures </li></ul><ul><li>1 fungemia - blood cultures </li></ul><ul><li>1 Aspergillus niger inf: Pneumonia - BAL culture + biopsy </li></ul><ul><li>Median day to FI : 12 (range 6 - 20) </li></ul><ul><li>All patients recieved treatment and 5 survived </li></ul>
  10. 10. LTX prophylaxis; Results late FI : Placebo group <ul><li>Invasive fungal infections </li></ul><ul><li>4 Candida albicans inf: 1 peritonitis - abdomen cultures </li></ul><ul><li>3 disseminated - autopsy findings </li></ul><ul><li>1 Aspergillosis: Disseminated - autopsy finding </li></ul><ul><li>Median day to FI : 150 (range 41 - 365) </li></ul><ul><li>2 of 5 patients recieved treatment and 1was cured </li></ul>
  11. 11. LTX prophylaxis; Results late FI : AmBisome group <ul><li>Invasive fungal infections </li></ul><ul><li>3 Aspergillus spp inf: 1 pneumonia – autopsy findings </li></ul><ul><li>2 disseminated – autopsy findings </li></ul><ul><li>1 Candida albicans: Cholangitis - cultures </li></ul><ul><li>Median day to FI : 81 (range 39 - 325) </li></ul><ul><li>1 of 4 patients recieved treatment and was cured </li></ul>
  12. 12. AmBisome treatment Solid organ transplant recipients, 10 year data
  13. 13. SOT patients <ul><li>Patients treated between Jan 1989 - March 1999 </li></ul><ul><li>196 solid organ transplant recipients </li></ul><ul><li>220 episodes of AmBisome treatment </li></ul><ul><ul><li>56 for a verified infections </li></ul></ul><ul><ul><li>79 for a suspected infections </li></ul></ul><ul><ul><li>85 as prophylaxis </li></ul></ul><ul><li>106 males </li></ul><ul><li>90 females </li></ul><ul><li>Median age was 42 years, range 1 - 72 </li></ul>
  14. 14. SOT patients <ul><li>123 liver (LTX) transplant recipients </li></ul><ul><li>3 liver and bone marrow transplant recipients </li></ul><ul><li>5 liver and kidney transplant recipients </li></ul><ul><li>42 kidney (KTX) transplant recipients </li></ul><ul><li>21 kidney & pancreas (KPTX) transplant recipients </li></ul><ul><li>1 kidney and insulin islet transplantation recipient </li></ul><ul><li>1 pancreas (P) transplant recipients </li></ul>
  15. 15. AmBisome treatment data in SOT <ul><li> Fungal Infection </li></ul><ul><li>AmBisome treatment Verified Suspected Prophylactic </li></ul><ul><li>Duration (days), </li></ul><ul><li> mean ± SD (median) 23±17(18) 18±15 (14) 16±19 (7) </li></ul><ul><li>range 4-81 1-80 1-83 </li></ul><ul><li>Max. dose (mg), </li></ul><ul><li>mean ± SD (median) 2.0±1 (1.8) 1.7±0.9 (1.4) 1.4±0.8 (1.0 ) </li></ul><ul><li> range 0.7-5.5 0.7-5 0.6-6 </li></ul><ul><li>Total dose (g), </li></ul><ul><li>mean ± SD (median) 1.7±1.7 (0.95) 1.4±1.3 (1.1) 0.6±0.5 (0.4) </li></ul><ul><li>range 0.05-8.1 0.06-8 0.03-2.4 </li></ul>
  16. 16. Days with AmBisome
  17. 17. AmBisome dose (mg/kg/d)
  18. 18. Total dose AmBisome (gram)
  19. 19. Adverse events in SOT <ul><li>335 adverse events were reported </li></ul><ul><li>9 (3%) were regarded as caused by AmBisome treatment </li></ul><ul><ul><li>6 Lumbago </li></ul></ul><ul><ul><li>2 Lumbago combined with chills </li></ul></ul><ul><ul><li>1 Lumbago with dyspnea </li></ul></ul><ul><li>No anaphylactic reaction was reported </li></ul><ul><li>224 (67%) of the adverse events were regarded as probably related to AmBisome </li></ul><ul><li>112 (33%) of the adverse events were regarded as not related to AmBisome </li></ul>
  20. 20. Kidney function before, during and after AmBisome treatment measured as S-creatinine
  21. 21. Efficacy; Suspected FI in SOT <ul><li>75 patients recieved 79 episodes of treatment for suspected FI </li></ul><ul><li>57 patients survived with clearance of symptoms and 10 died with no FI at autopsy </li></ul><ul><li>7 patients died, no autopsy was performed </li></ul><ul><li>1 patient died with FI at autopsy ( Aspergillus. fum ) </li></ul><ul><li>Efficacy was shown in 67 out of 75 patients, 89 % </li></ul>
  22. 22. Proven invasive fungal infections in SOT <ul><li>A total of 56 proven infections were treated in 50 patients </li></ul><ul><li>38 LTX, 7 KTX and 5 KPTX recipients </li></ul><ul><ul><li>20 cholangitis (18 C. alb , 1 C. parapsilosis & 1 C. glabrata ) </li></ul></ul><ul><ul><li>14 perotonitis (13 C. albicans & 1 C. pelliculosa ) </li></ul></ul><ul><ul><li>14 fungemias (13 C. albicans & 1 C. glabrata ) </li></ul></ul><ul><ul><li>4 pneumonias (2 Asp . sp , 1 C. alb + glab , 1 C. alb .) </li></ul></ul><ul><ul><li>3 disseminated inf. ( C. alb .) </li></ul></ul><ul><ul><li>1 urinary tract infection ( C. alb ) </li></ul></ul>
  23. 23. Efficacy, proven invasive fungal infections in SOT <ul><li>Out of 50 patients with proven infections; </li></ul><ul><ul><li>14 patients died </li></ul></ul><ul><ul><li>10 were FI negative at autopsy </li></ul></ul><ul><ul><li>3 was positive for fungi at autopsy </li></ul></ul><ul><ul><li>1 was not autopsied </li></ul></ul><ul><li>Survival or mycotic clearance was found in 46 out of 50, 92% of the patients </li></ul>
  24. 24. Conclusion solid organ transplantation <ul><li>10 years experience of Ambisome treatment in solid organ transplant recipients at one single center has revealed: </li></ul><ul><li>AmBisome treatment was safe </li></ul><ul><li>AmBisome treatment was efficacious as seen as survival or mycotic clearance in 92% of proven fungal infections in SOT patients </li></ul><ul><li>Efficacy in suspected FI was 89 % clinical cures </li></ul>
  25. 25. General conclusion; prophylaxis & treatment in transplantation <ul><li>Prophylaxis with AmBisome </li></ul><ul><ul><li>Efficacious in Liver transplantation </li></ul></ul><ul><li>Treatment with AmBisome </li></ul><ul><ul><li>Efficacious and safe in solid organ transplantation </li></ul></ul>

×